remedycell
General Data
Reg Number
516155306
Sector
Biomed
Established
2020
No. of Employees
10
Stage
R&D
Additional Funding
1
Description
Clinical stage biopharmaceutical company focused on the development of cell-derived, cell-free, breakthrough therapies for areas of unmet need in fibrotic diseases.
Technology
Remedy Cell is harnessing the therapeutic of MSC-derived secretomes to treat fibrotic disease.
Targeted Customers
People suffering from fibrotic disease, Physicians.
Management personnel
Ayelet Dilion-Mashiah - CEO
Winning details
Route name
Winning year
Startup Fund
Startup Fund
2025
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2025